Buddlejasaponin IV
Product Specifications
UNSPSC Description
Buddlejasaponin IV (BS‐IV) exerts anti-inflammatory and cytotoxic effects against cancer cells[1].
Target Antigen
COX; NO Synthase
Type
Natural Products
Related Pathways
Immunology/Inflammation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/buddlejasaponin-iv.html
Solubility
10 mM in DMSO
Smiles
C[C@]12[C@]3(C=C[C@@]4([H])[C@]2(CC[C@]5([H])[C@@]4(CC[C@H](O[C@@]6([H])[C@@H]([C@H]([C@@H](O)[C@@H](C)O6)O[C@]7([H])O[C@@H]([C@@H](O)[C@H](O)[C@H]7O)CO)O[C@]8([H])O[C@@H]([C@@H](O)[C@H](O)[C@H]8O)CO)[C@@]5(C)CO)C)C)[C@@]9([H])[C@](CO3)(CCC(C)(C)C9)[C@@H](O)C1
Molecular Weight
943.12
References & Citations
[1]Young Sun Hwang, et al. Buddlejasaponin IV induces cell cycle arrest at G2/M phase and apoptosis in immortalized human oral keratinocytes. Phytother Res. 2011 Oct;25(10):1503-10.|[2]Jong-Heon Won, et al. Anti-inflammatory effect of buddlejasaponin IV through the inhibition of iNOS and COX-2 expression in RAW 264.7 macrophages via the NF-kappaB inactivation. Br J Pharmacol. 2006 May;148(2):216-25.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-125131/Buddlejasaponin-IV-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-125131/
Clinical Information
No Development Reported
CAS Number
139523-30-1
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6159306-01 0.1 mL
PCDH11Y (Protocadherin 11 Y-linked, PCDH11X Protocadherin 11 X-linked) (PE)
Ask
View Details 
MBS6159306-02 5x 0.1 mL
PCDH11Y (Protocadherin 11 Y-linked, PCDH11X Protocadherin 11 X-linked) (PE)
Ask
View Details 